Form 4: WAFD SVP & PAO Sanden Reports Stock Option Grant
Insider Transaction Report
Blayne Sanden, SVP & Principal Accounting Officer of WAFD Inc., reported the acquisition of 456 non-qualified stock options and beneficial ownership of 4,383 common shares.
Summary
- Blayne Sanden, Senior Vice President and Principal Accounting Officer of WAFD INC, reported changes in beneficial ownership of the company's securities.
- Sanden beneficially owns 4,383 shares of WAFD common stock directly.
- On January 2, 2026, Sanden acquired 456 non-qualified stock options with an exercise price of $32.13 per share.
- These 456 newly acquired options will cliff-vest on January 2, 2029, and have an expiration date of January 2, 2036.
- The transaction was made pursuant to a Rule 10b5-1(c) plan.
- Sanden also holds other non-qualified stock options for a total of 3,069 shares from previous grants, with various exercise prices ranging from $25.50 to $36.46 and expiration dates between October 31, 2029, and February 28, 2035.
Sentiment
Score: 6
Explanation: Neutral to slightly positive. The filing reports a standard executive equity compensation grant, which is a positive for aligning management incentives but does not contain new material financial or operational news to significantly impact sentiment.
Positives
- An executive, Blayne Sanden, received a grant of 456 non-qualified stock options, which aligns management's long-term interests with shareholder value.
- The transaction was executed under a Rule 10b5-1(c) plan, indicating a pre-arranged and structured approach to equity compensation, enhancing transparency and reducing potential insider trading concerns.
Future Outlook
NA
Industry Context
This Form 4 filing is a routine disclosure of an insider transaction, specifically an equity compensation grant. Such grants are standard practice in publicly traded companies to incentivize executives and align their interests with long-term shareholder value. It does not provide broader industry trends or competitive analysis.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Insider Trading Policy Adherence | The reported transaction was executed under a Rule 10b5-1(c) plan, which is a pre-arranged trading plan for equity securities. | 01/02/2026 | This demonstrates adherence to corporate governance best practices for insider trading, enhancing transparency and mitigating risks associated with discretionary insider trades. |
Stakeholder Impact
- Shareholders: The grant of stock options to an executive aligns management's incentives with shareholder interests, potentially encouraging long-term value creation.
- Employees (Executive): Blayne Sanden, as an executive, receives equity compensation, which is a key component of their overall remuneration package.
Next Steps
- The 456 non-qualified stock options granted on January 2, 2026, are scheduled to cliff-vest on January 2, 2029.
- The 456 non-qualified stock options granted on January 2, 2026, are scheduled to expire on January 2, 2036.
Key Dates
| Date | Description |
|---|---|
| 10/31/2022 | Date exercisable for 424 non-qualified stock options with an exercise price of $36.46. |
| 10/31/2023 | Date exercisable for 829 non-qualified stock options with an exercise price of $26.12. |
| 10/31/2024 | Date exercisable for 383 non-qualified stock options with an exercise price of $32.49. |
| 10/31/2025 | Date exercisable for 316 non-qualified stock options with an exercise price of $33.36. |
| 01/02/2026 | Date of acquisition for 456 non-qualified stock options with an exercise price of $32.13. |
| 01/06/2026 | Signature date of the Form 4 filing by Kelli Holz, Attorney-in-fact. |
| 10/31/2026 | Date exercisable for 620 non-qualified stock options with an exercise price of $25.50. |
| 02/28/2028 | Date exercisable for 497 non-qualified stock options with an exercise price of $29.59. |
| 01/02/2029 | Cliff-vesting date for 456 non-qualified stock options acquired on 01/02/2026. |
| 10/31/2029 | Expiration date for 424 non-qualified stock options with an exercise price of $36.46. |
| 10/31/2030 | Expiration date for 829 non-qualified stock options with an exercise price of $26.12. |
| 10/31/2031 | Expiration date for 383 non-qualified stock options with an exercise price of $32.49. |
| 10/31/2032 | Expiration date for 316 non-qualified stock options with an exercise price of $33.36. |
| 10/31/2033 | Expiration date for 620 non-qualified stock options with an exercise price of $25.50. |
| 02/28/2035 | Expiration date for 497 non-qualified stock options with an exercise price of $29.59. |
| 01/02/2036 | Expiration date for 456 non-qualified stock options acquired on 01/02/2026. |
Recommendation
holdThis Form 4 filing reports a routine grant of non-qualified stock options to a key executive, Blayne Sanden, as part of their compensation package. While it aligns management incentives with shareholder value, it does not present new material information that would significantly alter the investment thesis for WAFD INC. The transaction was executed under a Rule 10b5-1 plan, indicating a pre-scheduled event rather than a discretionary trade based on new information. Therefore, a 'hold' recommendation is appropriate as this filing does not provide a strong catalyst for either buying or selling the stock.
Keywords
WAFD INC, WAFD, Blayne Sanden, Form 4, Insider Transaction, Stock Options, Equity Compensation, SVP, Principal Accounting Officer, Beneficial Ownership, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.